Literature DB >> 28522333

Development of QSARs for parameterizing Physiology Based ToxicoKinetic models.

Dimosthenis Α Sarigiannis1, Krystalia Papadaki2, Periklis Kontoroupis2, Spyros P Karakitsios3.   

Abstract

A Quantitative Structure Activity Relationship (QSAR) model was developed in order to predict physicochemical and biochemical properties of industrial chemicals of various groups. This model was based on the solvation equation, originally proposed by Abraham. In this work Abraham's solvation model got parameterized using artificial intelligence techniques such as artificial neural networks (ANNs) for the prediction of partitioning into kidney, heart, adipose, liver, muscle, brain and lung for the estimation of the bodyweight-normalized maximal metabolic velocity (Vmax) and the Michaelis - Menten constant (Km). Model parameterization using ANNs was compared to the use of non-linear regression (NLR) for organic chemicals. The coupling of ANNs with Abraham's solvation equation resulted in a model with strong predictive power (R2 up to 0.95) for both partitioning and biokinetic parameters. The proposed model outperformed other QSAR models found in the literature, especially with regard to the estimation and prediction of key biokinetic parameters such as Km. The results show that the physicochemical descriptors used in the model successfully describe the complex interactions of the micro-processes governing chemical distribution and metabolism in human tissues. Moreover, ANNs provide a flexible mathematical framework to capture the non-linear biochemical and biological interactions compared to less flexible regression techniques.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Abraham's solvation equation; Artificial neural networks; Metabolic constants; QSARs; Tissue/ blood partition coefficients

Mesh:

Substances:

Year:  2017        PMID: 28522333     DOI: 10.1016/j.fct.2017.05.029

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  5 in total

Review 1.  Considerations for Improving Metabolism Predictions for In Vitro to In Vivo Extrapolation.

Authors:  Marjory Moreau; Pankajini Mallick; Marci Smeltz; Saad Haider; Chantel I Nicolas; Salil N Pendse; Jeremy A Leonard; Matthew W Linakis; Patrick D McMullen; Rebecca A Clewell; Harvey J Clewell; Miyoung Yoon
Journal:  Front Toxicol       Date:  2022-04-29

2.  Opportunities and challenges related to saturation of toxicokinetic processes: Implications for risk assessment.

Authors:  Yu-Mei Tan; Hugh A Barton; Alan Boobis; Rachel Brunner; Harvey Clewell; Rhian Cope; Jeffrey Dawson; Jeanne Domoradzki; Peter Egeghy; Pankaj Gulati; Brandall Ingle; Nicole Kleinstreuer; Kelly Lowe; Anna Lowit; Elizabeth Mendez; David Miller; Jeffrey Minucci; James Nguyen; Alicia Paini; Monique Perron; Katherine Phillips; Hua Qian; Tharacad Ramanarayanan; Fiona Sewell; Philip Villanueva; John Wambaugh; Michelle Embry
Journal:  Regul Toxicol Pharmacol       Date:  2021-10-28       Impact factor: 3.598

Review 3.  IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making.

Authors:  Xiaoqing Chang; Yu-Mei Tan; David G Allen; Shannon Bell; Paul C Brown; Lauren Browning; Patricia Ceger; Jeffery Gearhart; Pertti J Hakkinen; Shruti V Kabadi; Nicole C Kleinstreuer; Annie Lumen; Joanna Matheson; Alicia Paini; Heather A Pangburn; Elijah J Petersen; Emily N Reinke; Alexandre J S Ribeiro; Nisha Sipes; Lisa M Sweeney; John F Wambaugh; Ronald Wange; Barbara A Wetmore; Moiz Mumtaz
Journal:  Toxics       Date:  2022-05-01

4.  Health Risk Assessment of Ortho-Toluidine Utilising Human Biomonitoring Data of Workers and the General Population.

Authors:  Pasi Huuskonen; Spyros Karakitsios; Bernice Scholten; Joost Westerhout; Dimosthenis A Sarigiannis; Tiina Santonen
Journal:  Toxics       Date:  2022-04-25

Review 5.  Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials.

Authors:  Wells Utembe; Harvey Clewell; Natasha Sanabria; Philip Doganis; Mary Gulumian
Journal:  Nanomaterials (Basel)       Date:  2020-06-29       Impact factor: 5.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.